These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 24656042)

  • 1. Clec12a: quieting the dead.
    Yamasaki S
    Immunity; 2014 Mar; 40(3):309-11. PubMed ID: 24656042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clec12a is an inhibitory receptor for uric acid crystals that regulates inflammation in response to cell death.
    Neumann K; Castiñeiras-Vilariño M; Höckendorf U; Hannesschläger N; Lemeer S; Kupka D; Meyermann S; Lech M; Anders HJ; Kuster B; Busch DH; Gewies A; Naumann R; Groß O; Ruland J
    Immunity; 2014 Mar; 40(3):389-99. PubMed ID: 24631154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The uric acid crystal receptor Clec12A potentiates type I interferon responses.
    Li K; Neumann K; Duhan V; Namineni S; Hansen AL; Wartewig T; Kurgyis Z; Holm CK; Heikenwalder M; Lang KS; Ruland J
    Proc Natl Acad Sci U S A; 2019 Sep; 116(37):18544-18549. PubMed ID: 31451663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal structure of the complex of CLEC12A and an antibody that interferes with binding of diverse ligands.
    Mori S; Nagae M; Yamasaki S
    Int Immunol; 2024 Apr; 36(6):279-290. PubMed ID: 38386511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How to regulate neutrophils in gout.
    So A
    Arthritis Res Ther; 2013; 15(5):118. PubMed ID: 24063679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-type lectin domain family 12, member A: A common denominator in Behçet's syndrome and acute gouty arthritis.
    Oğuz AK; Yılmaz S; Akar N; Özdağ H; Gürler A; Ateş A; Oygür ÇŞ; Kılıçoğlu SS; Demirtaş S
    Med Hypotheses; 2015 Aug; 85(2):186-91. PubMed ID: 25957656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanistic insights into the C-type lectin receptor CLEC12A-mediated immune recognition of monosodium urate crystal.
    Tang H; Xiao Y; Qian L; Wang Z; Lu M; Yao N; Zhou T; Tian F; Cao L; Zheng P; Dong X
    J Biol Chem; 2024 Mar; 300(3):105765. PubMed ID: 38367667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the Expression, Oligomerisation and Signaling of the Inhibitory Receptor CLEC12A by Cysteine Residues in the Stalk Region.
    Vitry J; Paré G; Murru A; Charest-Morin X; Maaroufi H; McLeish KR; Naccache PH; Fernandes MJ
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human MICL (CLEC12A) is differentially glycosylated and is down-regulated following cellular activation.
    Marshall AS; Willment JA; Pyz E; Dennehy KM; Reid DM; Dri P; Gordon S; Wong SY; Brown GD
    Eur J Immunol; 2006 Aug; 36(8):2159-69. PubMed ID: 16838277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of the myeloid inhibitory receptor CLEC12A correlates with disease activity and cytokines in early rheumatoid arthritis.
    Vaillancourt M; Desaulniers P; Paré G; Pagé N; Lachhab A; Kerever A; Julien AS; Amiable N; Pelletier M; Tessier PA; Bessette L; Michou L; Fortin PR; Fernandes MJ
    Sci Rep; 2021 May; 11(1):11248. PubMed ID: 34045571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-Type Lectin-Like Receptors: Head or Tail in Cell Death Immunity.
    Drouin M; Saenz J; Chiffoleau E
    Front Immunol; 2020; 11():251. PubMed ID: 32133013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycobacterial mycolic acids trigger inhibitory receptor Clec12A to suppress host immune responses.
    Nishimura N; Tomiyasu N; Torigoe S; Mizuno S; Fukano H; Ishikawa E; Katano H; Hoshino Y; Matsuo K; Takahashi M; Izumi Y; Bamba T; Akashi K; Yamasaki S
    Tuberculosis (Edinb); 2023 Jan; 138():102294. PubMed ID: 36542980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The CLEC12A receptor marks human basophils: Potential implications for minimal residual disease detection in acute myeloid leukemia.
    Toft-Petersen M; Stidsholt Roug A; Plesner T; Ebbesen L; Brown GD; Nederby L
    Cytometry B Clin Cytom; 2018 May; 94(3):520-526. PubMed ID: 28718199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Fusion of
    Dhungel BP; Monteuuis G; Giardina C; Tabar MS; Feng Y; Metierre C; Ho S; Nagarajah R; Fontaine ARM; Shah JS; Gokal D; Bailey CG; Schmitz U; Rasko JEJ
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Understanding inhibitory receptor function in neutrophils through the lens of CLEC12A.
    McLeish KR; Fernandes MJ
    Immunol Rev; 2023 Mar; 314(1):50-68. PubMed ID: 36424898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterisation of murine MICL (CLEC12A) and evidence for an endogenous ligand.
    Pyz E; Huysamen C; Marshall AS; Gordon S; Taylor PR; Brown GD
    Eur J Immunol; 2008 Apr; 38(4):1157-63. PubMed ID: 18350551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. F-actin is an evolutionarily conserved damage-associated molecular pattern recognized by DNGR-1, a receptor for dead cells.
    Ahrens S; Zelenay S; Sancho D; Hanč P; Kjær S; Feest C; Fletcher G; Durkin C; Postigo A; Skehel M; Batista F; Thompson B; Way M; Reis e Sousa C; Schulz O
    Immunity; 2012 Apr; 36(4):635-45. PubMed ID: 22483800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The C-type lectin Clec12A present on mouse and human dendritic cells can serve as a target for antigen delivery and enhancement of antibody responses.
    Lahoud MH; Proietto AI; Ahmet F; Kitsoulis S; Eidsmo L; Wu L; Sathe P; Pietersz S; Chang HW; Walker ID; Maraskovsky E; Braley H; Lew AM; Wright MD; Heath WR; Shortman K; Caminschi I
    J Immunol; 2009 Jun; 182(12):7587-94. PubMed ID: 19494282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-mediated targeting of antigen to C-type lectin-like receptors Clec9A and Clec12A elicits different vaccination outcomes.
    Macri C; Dumont C; Panozza S; Lahoud MH; Caminschi I; Villadangos JA; Johnston AP; Mintern JD
    Mol Immunol; 2017 Jan; 81():143-150. PubMed ID: 27978488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLEC12A-Mediated Antigen Uptake and Cross-Presentation by Human Dendritic Cell Subsets Efficiently Boost Tumor-Reactive T Cell Responses.
    Hutten TJ; Thordardottir S; Fredrix H; Janssen L; Woestenenk R; Tel J; Joosten B; Cambi A; Heemskerk MH; Franssen GM; Boerman OC; Bakker LB; Jansen JH; Schaap N; Dolstra H; Hobo W
    J Immunol; 2016 Oct; 197(7):2715-25. PubMed ID: 27566820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.